基本信息
浏览量:0
职业迁徙
个人简介
Professor Ruoslahti currently studies peptides that home to specific targets in the body, such as tumors and atherosclerotic plaques. These peptides, which usually bind to receptors in the vessels of the target tissue, can be used to selectively deliver diagnostic probes and drugs to the target. The latest development is the discovery of homing peptides with tumor-penetrating properties that can enhance tumor accumulation of anti-cancer drugs, even when co-administered with the drug without chemical coupling. New anti-cancer therapies that use these peptides for targeted delivery improve the activity and reduce the side effects of existing anti-cancer drugs. Dr. Ruoslahti’s lab is also using these properties to design new nanoparticle-based drugs aimed at cancer and other diseases.
研究兴趣
论文共 331 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Alberto G Arias, Laura Tovar-Martinez, Eliana K Asciutto,Aman Mann,Kristina Posnograjeva, Lorena Simon Gracia, Miriam Royo,Maarja Haugas, Tambet Teesalu, Cristian Smulski,Erkki Ruoslahti,Pablo Scodeller
crossref(2024)
openalex(2023)
bioRxiv : the preprint server for biology (2023)
加载更多
作者统计
#Papers: 332
#Citation: 55812
H-Index: 110
G-Index: 234
Sociability: 7
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn